Avista Healthcare Partners Acquires EBI Bone Healing Division from Highridge Medical

Avista-backed EBI Acquires Xstim from Precision Medical Products

June 18, 2026

Healthcare Services

EBI, an Avista Healthcare Partners portfolio company, announced the acquisition of Xstim, a Precision Medical Products division focused on next-generation, wearable, non-invasive bone growth stimulation for spine fusion. The deal expands EBI’s bone healing portfolio by adding Xstim’s capacitively coupled electrical stimulation technology across lumbar spinal fusion, nonunion fractures, and failed joint fusion applications.

Avista Healthcare Partners Acquires Bentec Medical

April 9, 2026

Medical Devices

Avista Healthcare Partners acquired Bentec Medical, a Woodland, California manufacturer of complex silicone-based medical device components and finished goods. The deal was announced April 8, 2026, and financial terms were not disclosed.

H.I.G. Capital Acquires ZimVie's Spine Business, Rebrands as Highridge Medical

April 1, 2024

Medical Devices

An affiliate of H.I.G. Capital has completed the acquisition of the Spine division of ZimVie, Inc. The acquired business will operate independently under the new name Highridge Medical, headquartered in Westminster, Colorado, and H.I.G. plans to invest in R&D, product innovation and strategic growth to build a leading privately held spine platform.

Avista Capital Partners Acquires Taconic Biosciences

November 1, 2022

Biotechnology

Avista Capital Partners has acquired Taconic Biosciences from H.I.G. Capital. Taconic, a Rensselaer, New York–based provider of genetically engineered murine research models and related preclinical services, will leverage Avista's healthcare investing expertise to pursue organic growth and strategic acquisitions in the GEMs market.

Envista Acquires Osteogenics Biomedical Business

May 17, 2022

Medical Devices

Envista Holdings Corporation entered into a definitive agreement to acquire Osteogenics Biomedical, Allotech LLC and OBI Biologics (collectively “Osteogenics”), a developer of regenerative dental bone grafting products sold primarily under the Cytoplast brand. The deal, subject to customary regulatory approvals and expected to close in the third quarter, expands Envista’s capabilities in regenerative solutions for periodontists, oral and maxillofacial surgeons and implant dentistry; the transaction is not subject to a financing condition or shareholder vote.

Venture Life Group plc Acquires BBI Healthcare (BBIH) from Exponent

June 7, 2021

Consumer Products

Venture Life Group plc has agreed to acquire BBI Healthcare (BBIH), the consumer self-care division of BBI Group, from private equity owner Exponent. BBIH — owner of brands including Balance Activ, GlucoGel and LIFT with broad UK retail distribution and a Swedish manufacturing facility — was transformed under Exponent, delivering strong EBITDA growth; its managing director will leave on completion while the chairman will remain with BBI Group.